Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine.

[1]  S. Szu,et al.  Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever , 1988, Journal of clinical microbiology.

[2]  C. Jones,et al.  Full 1H NMR assignment and detailed O-acetylation patterns of capsular polysaccharides from Neisseria meningitidis used in vaccine production. , 1996, Carbohydrate research.

[3]  S. Szu,et al.  Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi , 1989, Infection and immunity.

[4]  J. Murphy,et al.  Multiple-drug-resistant Salmonella typhi. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Levine,et al.  Vaccination against typhoid fever: present status. , 1994, Bulletin of the World Health Organization.

[6]  R. Harris.  Nuclear magnetic resonance spectroscopy : a physicochemical view , 1985 .

[7]  J. Shiloach,et al.  Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines , 1994, Infection and immunity.

[8]  S. Szu,et al.  Relation between structure and immunologic properties of the Vi capsular polysaccharide , 1991, Infection and immunity.

[9]  J. Robbins,et al.  Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. , 1984, The Journal of infectious diseases.

[10]  D. Musher,et al.  Natural and vaccine-related immunity to Streptococcus pneumoniae. , 1986, The Journal of infectious diseases.

[11]  R. Thapa,et al.  Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. , 1987, The New England journal of medicine.

[12]  M. Popoff,et al.  The Vi antigen of Salmonella typhi , 1996 .

[13]  R. Schneerson,et al.  Characterization of the Salmonella paratyphi C Vi polysaccharide , 1989, Infection and immunity.

[14]  D. Bundle,et al.  Synthesis of α- and β-linked tyvelose epitopes of the Trichinella spiralis glycan: 2-acetamido-2-deoxy-3-O-(3,6-dideoxy-d-arabino-hexopyranosyl)-β-d-galactopyranosides , 1996 .

[15]  S. Szu,et al.  Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals , 1987, The Journal of experimental medicine.

[16]  C. Hellerqvist,et al.  Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella typhimurium 395 ms , 1968 .

[17]  S. Singh,et al.  Blood-films int eh diagnosis of malaria , 1989 .

[18]  C. Hellerqvist,et al.  Structural studies on the O-specific side chains of the cell wall lipopolysaccharides from Salmonella typhi and S. enteritidis. , 1969, Acta chemica Scandinavica.

[19]  J. Robbins,et al.  Identification of Salmonella typhi in faecal specimens by an antiserum-agar method. , 1980, Journal of medical microbiology.

[20]  J. Robbins,et al.  Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. , 1996, Vaccine.

[21]  R. K. Marwaha,et al.  Multidrug resistant Salmonella typhi. , 1991, The Pediatric infectious disease journal.

[22]  M. Levine,et al.  Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines. , 1986, The Journal of infectious diseases.

[23]  J. Shiloach,et al.  Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker , 1997, Infection and immunity.

[24]  R. Schneerson,et al.  PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER , 1987, The Lancet.

[25]  B. Szewczyk,et al.  Immunochemical properties of Vi antigen from Salmonella typhi Ty2: presence of two antigenic determinants , 1980, Infection and immunity.

[26]  K. Heyns,et al.  Strukturaufklärung des vi-antigens aus Citrobacter freundii (E. coli) 5396/38 , 1967 .

[27]  D. Bundle,et al.  Antigenic determinants of Salmonella serogroups A and D1. Synthesis of trisaccharide glycosides for use as artificial antigens. , 1982, Carbohydrate research.